サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1467759

トランスフェクション試薬と機器市場レポート：製品、技術、用途、エンドユーザー、地域、2024～2032年

Transfection Reagents and Equipment Market Report by Product, Technology, Application, End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 138 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
トランスフェクション試薬と機器市場レポート：製品、技術、用途、エンドユーザー、地域、2024～2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

トランスフェクション試薬と機器の世界市場規模は、2023年に9億7,110万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに17億6,690万米ドルに達し、2024～2032年の間に6.7%の成長率（CAGR）を示すと予測しています。

トランスフェクション試薬と機器は、in vitroとin vivoでの真核細胞の遺伝子発現を調節するのに役立ちます。これらの試薬は、研究者が安定した細胞株を作製し、発現用遺伝子インサートや低分子干渉RNA（siRNA）を有するデオキシリボ核酸（DNA）プラスミドを導入することを可能にします。現在、タンパク質合成、細胞の成長と発達、遺伝的機能の研究のための実行可能な分析ツールとして使用されています。これに加えて、トランスフェクション試薬と機器は、十分な量の組換えヒト治療用タンパク質をコスト効率よく迅速に生産できるため、r-タンパク質、抗体、ワクチン用ウイルスベクターの生産においても支持を集めています。

トランスフェクション試薬と機器の市場動向：

コロナウイルス感染症（COVID-19）の世界の流行により、多くの国の行政機関がワクチン接種の促進に注力しています。しかし、新しい亜種の出現により、これらのワクチンが提供する防御や免疫は短命です。その結果、革新的な戦略を開発するため、あるいはウイルス感染と闘うために既存の治療法を再利用するために、トランスフェクション試薬と機器の必要性が高まっています。これとは別に、精密医療と質の高い腫瘍学的治療に対する需要の高まりと相まって、新たながん変異体の迅速な検出が、がん研究と薬剤開発におけるトランスフェクション試薬と機器の採用を促進しています。さらに、遺伝的問題に起因する希少疾患の治療に遺伝子治療が使用され始めていることも、市場の成長を促しています。さらに、世界中で交通死亡事故が増加しているため、損傷した組織の機能的代替物を開発するための組織工学の需要が大幅に増加しています。これが市場の成長を後押ししています。このほか、トランスフェクション技術における最近の進歩や、製薬・バイオテクノロジーセグメントへの投資の増加が市場を牽引すると予測されています。

本レポートで扱う主要質問

  • 2023年のトランスフェクション試薬と機器の世界市場規模は？
  • 2024～2032年にかけてのトランスフェクション試薬と機器の世界市場の予想成長率は？
  • トランスフェクション試薬と機器の世界市場を牽引する主要因は？
  • COVID-19がトランスフェクション試薬と機器の世界市場に与えた影響は？
  • トランスフェクション試薬と機器の世界市場における製品別の区分は？
  • 技術別のトランスフェクション試薬と機器の世界市場内訳は？
  • トランスフェクション試薬と機器の世界市場の用途別区分は？
  • エンドユーザー別のトランスフェクション試薬と機器の世界市場内訳は？
  • トランスフェクション試薬と機器の世界市場における主要地域は？
  • トランスフェクション試薬と機器の世界市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のトランスフェクション試薬と機器市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 試薬
  • 機器

第7章 市場内訳：技術別

  • 生化学ベースのトランスフェクション
  • 物理的トランスフェクション
  • ウイルスベクターベースのトランスフェクション

第8章 市場内訳：用途別

  • バイオメディカル調査
  • タンパク質生産
  • 治療デリバリー

第9章 市場内訳：エンドユーザー別

  • 製薬・バイオ企業
  • 学術・研究機関

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Bio-Rad Laboratories Inc.
    • Lonza Group AG
    • MaxCyte Inc.
    • Merck KGaA
    • Mirus Bio LLC
    • OriGene Technologies Inc.
    • PerkinElmer Inc.
    • Polyplus-transfection SA
    • Promega Corporation
    • PromoCell GmbH
    • Qiagen N.V.
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Transfection Reagents and Equipment Market: Major Drivers and Challenges
  • Figure 2: Global: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Transfection Reagents and Equipment Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Transfection Reagents and Equipment Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Transfection Reagents and Equipment Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Transfection Reagents and Equipment Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Transfection Reagents and Equipment Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Transfection Reagents and Equipment (Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Transfection Reagents and Equipment (Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Transfection Reagents and Equipment (Equipment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Transfection Reagents and Equipment (Equipment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Transfection Reagents and Equipment (Biochemical Based Transfection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Transfection Reagents and Equipment (Biochemical Based Transfection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Transfection Reagents and Equipment (Physical Transfection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Transfection Reagents and Equipment (Physical Transfection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Transfection Reagents and Equipment (Viral-Vector Based Transfection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Transfection Reagents and Equipment (Viral-Vector Based Transfection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Transfection Reagents and Equipment (Biomedical Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Transfection Reagents and Equipment (Biomedical Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Transfection Reagents and Equipment (Protein Production) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Transfection Reagents and Equipment (Protein Production) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Transfection Reagents and Equipment (Therapeutic Delivery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Transfection Reagents and Equipment (Therapeutic Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Transfection Reagents and Equipment (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Transfection Reagents and Equipment (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Transfection Reagents and Equipment (Academics and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Transfection Reagents and Equipment (Academics and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: North America: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: North America: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: United States: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: United States: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Canada: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Canada: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Asia-Pacific: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Asia-Pacific: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: China: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: China: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Japan: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Japan: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: India: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: India: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: South Korea: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: South Korea: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Australia: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Australia: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Indonesia: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Indonesia: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Others: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Others: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Europe: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Europe: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Germany: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Germany: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: France: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: France: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: United Kingdom: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: United Kingdom: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Italy: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Italy: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Spain: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Spain: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Russia: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Russia: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Others: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Others: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Latin America: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Latin America: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Brazil: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Brazil: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Mexico: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Mexico: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Middle East and Africa: Transfection Reagents and Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Middle East and Africa: Transfection Reagents and Equipment Market: Breakup by Country (in %), 2023
  • Figure 77: Middle East and Africa: Transfection Reagents and Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Global: Transfection Reagents and Equipment Industry: SWOT Analysis
  • Figure 79: Global: Transfection Reagents and Equipment Industry: Value Chain Analysis
  • Figure 80: Global: Transfection Reagents and Equipment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transfection Reagents and Equipment Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Transfection Reagents and Equipment Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Transfection Reagents and Equipment Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Transfection Reagents and Equipment Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Transfection Reagents and Equipment Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Transfection Reagents and Equipment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Transfection Reagents and Equipment Market: Competitive Structure
  • Table 8: Global: Transfection Reagents and Equipment Market: Key Players
目次
Product Code: SR112024A4878

The global transfection reagents and equipment market size reached US$ 971.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,766.9 Million by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032.

Transfection reagents and equipment help modulate gene expression in eukaryotic cells in vitro and in vivo. They allow researchers to generate stable cell lines and introduce deoxyribonucleic acid (DNA) plasmids possessing gene inserts for expression and small interfering RNA (siRNA). They are currently being used as viable analytical tools for protein synthesis, cell growth and development, and facilitating the study of genetic functions. Besides this, as they provide cost-effective and rapid production of recombinant human therapeutic proteins in sufficient quantities, transfection reagents and equipment are also gaining traction in producing r-proteins, antibodies, and viral vectors for vaccines.

Transfection Reagents and Equipment Market Trends:

Due to the outbreak of coronavirus disease (COVID-19) globally, governing agencies of numerous countries are focusing on accelerating the vaccination drive. However, due to the emergence of new variants, the protection and immunity that these vaccines provide are short-lived. As a result, there is a rise in the need of transfection reagents and equipment to develop innovative strategies or alternatively repurpose existing treatments to fight against virus infection. Apart from this, rapid detection of new cancer variants, coupled with the escalating demand for precision medicine and high-quality oncology care, are driving the adoption of transfection reagents and equipment in cancer research and drug development. Moreover, the emerging use of gene therapies to treat rare diseases caused by genetic problems is impelling the market growth. Furthermore, due to the growing number of fatal road accidents across the globe, there is a significant rise in the demand for tissue engineering to develop functional substitutes for damaged tissues. This, in turn, is propelling the market growth. Besides this, recent advancements in transfection technologies, along with increasing investments in pharmaceutical and biotechnology sectors, are anticipated to drive the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global transfection reagents and equipment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, technology, application and end user.

Breakup by Product:

Reagents

Equipment

Breakup by Technology:

Biochemical Based Transfection

Physical Transfection

Viral-Vector Based Transfection

Breakup by Application:

Biomedical Research

Protein Production

Therapeutic Delivery

Breakup by End User:

Pharmaceutical and Biotechnology Companies

Academics and Research Institutes

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Bio-Rad Laboratories Inc., Lonza Group AG, MaxCyte Inc., Merck KGaA, Mirus Bio LLC, OriGene Technologies Inc., PerkinElmer Inc., Polyplus-transfection SA, Promega Corporation, PromoCell GmbH, Qiagen N.V. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global transfection reagents and equipment market in 2023?
  • 2. What is the expected growth rate of the global transfection reagents and equipment market during 2024-2032?
  • 3. What are the key factors driving the global transfection reagents and equipment market?
  • 4. What has been the impact of COVID-19 on the global transfection reagents and equipment market?
  • 5. What is the breakup of the global transfection reagents and equipment market based on the product?
  • 6. What is the breakup of the global transfection reagents and equipment market based on the technology?
  • 7. What is the breakup of the global transfection reagents and equipment market based on the application?
  • 8. What is the breakup of the global transfection reagents and equipment market based on the end user?
  • 9. What are the key regions in the global transfection reagents and equipment market?
  • 10. Who are the key players/companies in the global transfection reagents and equipment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transfection Reagents and Equipment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Equipment
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Biochemical Based Transfection
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Physical Transfection
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Viral-Vector Based Transfection
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Biomedical Research
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Protein Production
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Therapeutic Delivery
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical and Biotechnology Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academics and Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bio-Rad Laboratories Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Lonza Group AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 MaxCyte Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 Merck KGaA
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Mirus Bio LLC
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 OriGene Technologies Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 PerkinElmer Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Polyplus-transfection SA
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Promega Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 PromoCell GmbH
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Qiagen N.V.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis